Majority Of Claims In EpiPen Stock-Drop Suit Allowed To Proceed, Judge Rules
Mealey's (April 9, 2020, 2:21 PM EDT) -- NEW YORK — A federal judge in New York on April 6 ruled that lead plaintiffs in a securities class action against drugmaker Mylan N.V. and certain of its current and...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login